How does cerebral MCAO lead to spinal cord remyelination deficits that FJT can reverse?

OPEN

The abstract shows FJT promotes remyelination after cerebral stroke, but the mechanistic link between focal cerebral ischemia and distant spinal cord demyelination is not explained. Understanding this connection is crucial for targeting post-stroke white matter recovery. Gap type: unexplained_observation Source paper: Fujian tablet regulates the Foxo3a/GPX4 axis to promote remyelination and improve motor function in ischemic stroke. (2026, Journal of ethnopharmacology, PMID:40915372)

Priority: 0.80 Domain: stroke-recovery Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: How does cerebral MCAO lead to spinal cord remyelination deficits that FJT can reverse? is a 0.8 priority gap in stroke-recovery. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does cerebral MCAO lead to spinal cord remyelination deficits that FJT can reverse? — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.00

Avg Quality

Resolution

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps